0 items / CHF0.00

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

0 items / CHF0.00

zynlonta_1_

Click to enlarge

Previous product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/jemperli-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/jemperli-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/jemperli-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/jemperli-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/jemperli.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Jemperli (dostarlimab) CHF19,355.72

Back to products

Next product

Jakavi (ruxolitinib) CHF2,272.99

Zynlonta (loncastuximab tesirine-lpyl)

CHF27,746.55

Zynlonta (loncastuximab tesirine-lpyl) is a prescription medicine used to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after at least 2 prior systemic therapies.

Add to wishlist

Category: Oncology

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Zynlonta (loncastuximab tesirine-lpyl)”

Start typing to see products you are looking for.

No account yet?

Create an Account